TABLE 1.
Model | DNA in infected tissue | DNA in neurons/ganglia | RNA | Protein | Replication | Spread | Latency/Quiescence | Reactivation |
In vivo | ||||||||
Mice | ✓ | ✓ | ||||||
Rat | ✓ | ✓ | ✓ | |||||
Cotton rat | ✓ | ✓ | ✓ | |||||
Guinea pig* | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ? |
SCID-hu mouse/human xenograft† | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
In vitro | ||||||||
Rat primary/progenitor cells | ✓ | ✓ | ✓ | |||||
Immortalized human neuron-like cells | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Differentiated human neural progenitor lines | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
hiPSC-derived neurons | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
hESC-derived neurons | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
While many models support VZV infection and limited viral RNA and protein expression programs, VZV replication and spread are limited to guinea pigs and human cells that are permissive for the full lytic virus life cycle. hESC-derived neurons are the only model in which experimental reactivation of a quiescent VZV infection has been reliably achieved. It has been claimed that the guinea pig model supports experimental reactivation. *Most studies use guinea pig adapted VZV. †In human tissue graft.